A compact and automated ex vivo vessel culture system for the pulsatile pressure conditioning of human saphenous veins

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 3, 2016, Pages E204-E215

  Piola, Marco ^a   Prandi, Francesca ^b   Bono, Nina ^a   Soncini, Monica ^a   Penza, Eleonora ^b   Agrifoglio, Marco ^c   Polvani, Gianluca ^c   Pesce, Maurizio ^b   Fiore, Gianfranco Beniamino ^a  

^a POLITECNICO DI MILANO   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Coronary artery by pass grafting; ex vivo vessel culture system; Mechanical conditioning; Pulsatile pressure stimulation; Saphenous vein graft disease; Saphenous vein remodelling

Indexed keywords

GRAFTS; MECHANISMS;

BY PASS; CORONARY ARTERIES; CORONARY ARTERY BY-PASS GRAFTING; CULTURE SYSTEMS; EX VIVO VESSEL CULTURE SYSTEM; EX-VIVO; GRAFT DISEASE; MECHANICAL CONDITIONING; PRESSURE STIMULATION; PULSATILE PRESSURE STIMULATION; PULSATILE PRESSURES; SAPHENOUS VEIN; SAPHENOUS VEIN GRAFT DISEASE; SAPHENOUS VEIN REMODELING; VEIN GRAFTS;

GRAFTING (CHEMICAL);

POLY(METHYL METHACRYLATE);

ARTICLE; AUTOMATION; BIOMECHANICS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MOLECULAR MECHANICS; MORPHOLOGY; MUSCLE CELL; PRESSURE MEASUREMENT; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; TISSUE CULTURE; VASCULAR ENDOTHELIUM; VEIN BLOOD FLOW; VEIN DIAMETER; VEIN GRAFT DISEASE; VEIN WALL; VENOUS PRESSURE; AGED; DEVICES; FLUORESCENT ANTIBODY TECHNIQUE; IN VITRO STUDY; PHYSIOLOGY; PRESSURE; PROCEDURES; REPRODUCIBILITY; SAPHENOUS VEIN; TISSUE CULTURE TECHNIQUE;

AGED; AUTOMATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN VITRO TECHNIQUES; PRESSURE; REPRODUCIBILITY OF RESULTS; SAPHENOUS VEIN; TISSUE CULTURE TECHNIQUES;

EID: 84961203573     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1798     Document Type: Article

References (35)

1. Anwar MA, Shalhoub J, Lim CS et al. 2012; The effect of pressure-induced mechanical stretch on vascular wall differential gene expression. J Vasc Res 49: 463-478.
2. Berard X, Déglise S, Alonso F et al. 2013; Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins. J Vasc Surg 57: 1371-1382.
3. Berceli SA, Showalter DP, Sheppeck RA et al. 1990; Biomechanics of the venous wall under simulated arterial conditions. J Biomech 23: 985-989.
4. Bouten CV, Dankers PY, Driessen-Mol A et al. 2011; Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev 63: 221-241.
5. Clerin V, Gusic RJ, O'Brien J et al. 2002; Mechanical environment, donor age, and presence of endothelium interact to modulate porcine artery viability ex vivo. Ann Biomed Eng 30: 1117-1127.
6. Costantino ML, Bagnoli P, Dini G et al. 2004; A numerical and experimental study of compliance and collapsibility of preterm lamb tracheae. J. Biomech. 37: 1837-1847.
7. Dashwood MR, Loesch A. 2009; The saphenous vein as a bypass conduit: the potential role of vascular nerves in graft performance. Curr Vasc Pharmacol 7: 47-57.
8. Dashwood MR, Tsui JC. 2013; 'No-touch' saphenous vein harvesting improves graft performance in patients undergoing coronary artery bypass surgery: a journey from bedside to bench. Vascul Pharmacol 58: 240-250.
9. de Waard V, Arkenbout EK, Vos M et al. 2006; TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. Am J Pathol 168: 2027-2035.
10. Dummler S, Eichhorn S, Tesche C et al. 2011; Pulsatile ex vivo perfusion of human saphenous vein grafts under controlled pressure conditions increases MMP-2 expression. BioMed Eng OnLine 10: 62.
11. Goldman S, Zadina K, Moritz T et al. 2004; Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs cooperative study. J Am Coll Cardiol 44: 2149-2156.
12. Gusic RJ, Myung R, Petko M et al. 2005; Shear stress and pressure modulate saphenous vein remodeling ex vivo. J. Biomech. 38: 1760-1769.
13. Hoenicka M, Wiedemann L, Puehler T et al. 2010; Effects of shear forces and pressure on blood vessel function and metabolism in a perfusion bioreactor. Ann. Biomed. Eng. 38: 3706-3723.
14. Hoglund VJ, Dong XR, Majesky MW. 2010; Neointima formation: a local affair. Arterioscler Thromb Vasc Biol 30: 1877-1879.
15. John LCH. 2009; Biomechanics of coronary artery and bypass graft disease: potential new approaches. Ann Thorac Surg 87: 331-338.
16. Lemson MS, Tordoir JH, Daemen MJ et al. 2000; Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg 19: 336-350.
17. Martin I, Wendt D, Heberer M. 2004; The role of bioreactors in tissue engineering. Trends Biotechnol 22: 80-86.
18. Mitra AK, Gangahar DM, Agrawal DK. 2006; Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol 84: 115-124.
19. Miyakawa AA, Dallan LAO, Lacchini S et al. 2008; Human saphenous vein organ culture under controlled hemodynamic conditions. Clinics 63: 683-688.
20. Motwani JG, Topol EJ. 1998; Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97: 916-931.
21. Muto A, Model L, Ziegler K et al. 2010; Mechanisms of vein graft adaptation to the arterial circulation. Circulat J 74: 1501-1512.
22. Orr DE, Burg KJL. 2008; Design of a modular bioreactor to incorporate both perfusion flow and hydrostatic compression for tissue engineering applications. Ann. Biomed. Eng. 36: 1228-1241.
23. Owens CD. 2010; Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J. Vasc. Surg. 51: 736-746.
24. Parang P, Arora R. 2009; Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 25: 57-62.
25. Piola M, Soncini M, Prandi F et al. 2012; Tools and procedures for ex vivo vein arterialization, preconditioning and tissue engineering: a step forward to translation to combat the consequences of vascular graft remodeling. Recent Pat Cardiovasc Drug Discov 7: 186-195.
26. Saucy F, Probst H, Alonso F et al. 2010; Ex vivo pulsatile perfusion of human saphenous veins induces intimal hyperplasia and increased levels of the plasminogen activator inhibitor 1. Eur Surg Res 45: 50-59.
27. Severyn DA, Muluk SC, Vorp DA. 2004; The influence of hemodynamics and wall biomechanics on the thrombogenicity of vein segments perfused in vitro. J Surg Res 121: 31-37.
28. Stigler R, Steger C, Schachner T et al. 2012; The impact of distension pressure on acute endothelial cell loss and neointimal proliferation in saphenous vein grafts. Eur J Cardiothorac Surg 42: e74-79.
29. Stooker W, Gök M, Sipkema P et al. 2003; Pressure-diameter relationship in the human greater saphenous vein. Ann. Thorac. Surg. 76: 1533-1538.
30. Surowiec SM, Conklin BS, Li JS et al. 2000; A new perfusion culture system used to study human vein. J. Surg. Res. 88: 34-41.
31. Torsney E, Hu Y, Xu Q. 2005; Adventitial progenitor cells contribute to arteriosclerosis. Trends Cardiovasc Med 15: 64-68.
32. Tsui JC, Dashwood MR. 2002; Recent strategies to reduce vein graft occlusion: a need to limit the effect of vascular damage. Eur. J. Vasc. Endovasc. Surg. 23: 202-208.
33. Vismara R, Soncini M, Talò G et al. 2009; A bioreactor with compliance monitoring for heart valve grafts. Ann. Biomed. Eng. 38: 100-108.
34. Voisard R, Ramiz E, Baur R et al. 2010; Pulsed perfusion in a venous human organ culture model with a Windkessel function (pulsed perfusion venous HOC-model). Med Sci Monit 16: CR523-529.
35. Wallitt EJ, Jevon M, Hornick PI. 2007; Therapeutics of vein graft intimal hyperplasia: 100years on. Ann. Thorac. Surg. 84: 317-323.